UnPAXing the divergent roles of PAX2 and PAX8 in high-grade serous ovarian cancer LR Hardy, A Salvi, JE Burdette Cancers 10 (8), 262, 2018 | 41 | 2018 |
Expression of N-WASP is regulated by HiF1α through the hypoxia response element in the N-WASP promoter A Salvi, T Thanabalu Biochemistry and biophysics reports 9, 13-21, 2017 | 22 | 2017 |
WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels A Salvi, T Thanabalu Biochemical and biophysical research communications 482 (4), 1353-1359, 2017 | 21 | 2017 |
Verticillin A causes apoptosis and reduces tumor burden in high-grade serous ovarian cancer by inducing DNA damage A Salvi, CSM Amrine, JR Austin, KA Kilpatrick, A Russo, D Lantvit, ... Molecular cancer therapeutics 19 (1), 89-100, 2020 | 19 | 2020 |
Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling JA Colina, P Varughese, S Karthikeyan, A Salvi, DA Modi, JE Burdette Carcinogenesis 41 (5), 646-655, 2020 | 15 | 2020 |
PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer A Salvi, AN Young, AC Huntsman, MR Pergande, MA Korkmaz, ... Cell Death & Disease 13 (1), 1-13, 2022 | 14 | 2022 |
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome A Salvi, LR Hardy, KN Heath, S Watry, MR Pergande, SM Cologna, ... Neoplasia 36, 100866, 2023 | 8 | 2023 |
Detection of Ovarian Cancer Using Samples Sourced from the Vaginal Microenvironment MM Galey, AN Young, VZ Petukhova, M Wang, J Wang, A Salvi, A Russo, ... Journal of proteome research 19 (1), 503-510, 2019 | 6 | 2019 |
Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer BK Mize, A Salvi, Y Ren, JE Burdette, JR Fuchs Natural Product Reports 40 (7), 1250-1270, 2023 | 4 | 2023 |
N-WASP Attenuates Cell Proliferation and Migration through ERK2-Dependent Enhanced Expression of TXNIP YJ Chung, A Salvi, P Kalailingam, M Alnawaz, SH Tan, JY Pan, NS Tan, ... Biology 11 (4), 582, 2022 | 2 | 2022 |
Verticillin A causes DNA damage and apoptosis in high grade serous ovarian cancer A Salvi, J Austin, D Lantvit, J Burdette Cancer Research 79 (13_Supplement), 1864-1864, 2019 | 1 | 2019 |
Abstract B030: PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome A Salvi, LR Hardy, KN Heath, S Watry, MR Pergande, SM Cologna, ... Cancer Research 83 (2_Supplement_2), B030-B030, 2023 | | 2023 |
Abstract B71: Investigating the role of PAX8 in modulating the tumor microenvironment of high-grade serous ovarian cancer A Salvi, L Hardy, S Watry, M Pergande, SM Cologna, JE Burdette Clinical Cancer Research 26 (13_Supplement), B71-B71, 2020 | | 2020 |
Investigating the role of PAX8 in modulating the tumor microenvironment of high-grade serous ovarian cancer. A Salvi, L Hardy, S Watry, M Pergande, SM Cologna, JE Burdette CLINICAL CANCER RESEARCH 26 (13), 116-117, 2020 | | 2020 |
Regulation of Neural Wiskott Aldrich Syndrome (N-WASP) expression under hypoxic conditions. A Salvi, T Thanabalu MOLECULAR BIOLOGY OF THE CELL 25, 2014 | | 2014 |
ROLE OF WIP IN METASTASIS AND STUDY OF TRANSCRIPTIONAL REGULATION OF N-WASP AS Salvi | | |